| Value | ₹3.50 Cr |
|---|
BSE filing, NSE: RAINBOW. Summary written from the filing by ALFA Finder's alert engine.
Rainbow Childrens Medicare Ltd: key numbers
- Share price
- ₹1,204.80
- Market cap
- ₹12,237 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 42.9×Sector 52.0×
- Promoter holding
- 49.83%-0.01% QoQ
- FII holding
- 14.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rainbow Childrens Medicare Ltd
All →Rainbow Childrens Medicare Board Meeting Date
Rainbow Children's Medicare will hold a board meeting on 31-Oct-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the results.
Rainbow Childrens Medicare Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Rainbow Childrens Medicare Capacity Expansion
Rainbow Children’s Medicare entered a 60-year lease for 2 acres in Amaravati with APCRDA. The site will house a new 250-bed super speciality children’s hospital.
- From
- Andhra Pradesh Capital Region Development Authority (APCRDA)
- Execution
- 60 years
- hospital beds
- 250.0 beds
Rainbow Childrens Medicare Credit Rating
ICRA Limited has reaffirmed the [ICRA] AA (Stable) issuer rating for Rainbow Children's Medicare Limited. This periodic rating review confirms the company's existing credit standing.
Rainbow Childrens Medicare Management Change
Rainbow Childrens Medicare Limited has appointed Mr. Sudarshan Patodia as the Chief Financial Officer, effective September 23, 2026.
Rainbow Childrens Medicare Employee Stock Options
Rainbow Children's Medicare Limited granted 55,690 stock options to eligible employees under its ESOP 2025 scheme.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.